計算生物學市場：按類型、工具和地區分類

Computational Biology Market, By Type, By Tools, By Geography

出版日期: 2026年03月31日 | 出版商:

Coherent Market Insights | 英文 160 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計到2026年，計算生物學市場規模將達到107.6億美元，到2033年將達到338.6億美元。預計從2026年到2033年，該市場將以17.8%的複合年成長率成長。

報告範圍		報告詳情
基準年：	2025	2026年市場規模：	107.6億美元
歷史數據時期：	2020年至2024年	預測期：	2026年至2033年
2026年至2033年預測期間的複合年成長率：	17.80%	2033年市場規模預測：	338.6億美元

計算生物學旨在透過建立疾病的計算模型、利用患者數據對這些模型進行個人化客製化，並將其應用於改善診斷和治療，從而推動醫療保健的發展。這些患者模型被應用於癌症、心血管疾病和神經系統疾病等領域，用於發現新的風險生物標記、預測疾病進展、設計最佳治療方法以及識別新的藥物標靶。開發和應用患者特異性定量模型有助於理解、診斷和治療疾病。計算醫學可應用於分子醫學、生理學和解剖學等領域。透過整合生物醫學訊號處理、計算建模、機器學習和健康資訊學，可以開發出利用電子健康記錄、生理時間序列資料和基因組學的個人化醫療新方法。

市場動態

預計主要市場參與者將持續推出新產品、進行併購將推動全球運算生物學市場的成長。例如，2022年7月25日，總部位於美國的基因組編寫公司Replay完成了5,500萬美元的種子輪融資。本輪資金籌措由KKR和OMX Ventures主導，ARTIS Ventures、Lansdowne Partners、SALT、DeciBio Ventures和Axial也參與了投資。 Replay的基因組醫學工具包包含一系列用於編寫和遞送大型DNA的創新平台技術，其中包括高有效載荷容量的HSV遞送平台、低免疫抗原性細胞治療平台以及專有的基因組編寫平台。作為一家總部位於美國的基因組編寫公司，Replay致力於解決目前限制臨床進展的挑戰，例如提高有效載荷容量、降低成本、提升生產速度、產量和一致性，以及拓展基因組工程的可能性。

本次調查的主要特點

本研究揭示了各個細分市場的潛在商機，並為該市場說明了一個具有吸引力的投資提案矩陣。
此外，本研究還深入分析了市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要參與者採取的競爭策略。
本研究根據以下參數創建了全球計算生物學市場主要公司的概況：公司亮點、產品系列、關鍵亮點、財務表現和策略。
本研究涵蓋的主要公司包括 Accelrys、Certara、LP、Chemical Computing Group Inc.、Compugen、Ltd.、Entelos、Inc.（Rosa & Co. LLC）、Geneda AG、Insilico Biotechnology AG、Leadscope、Inc.、Nimbus Discovery LLC、Rhenovia Pharmaation AG、Leadscope、Inc.、Nimbus Discovery LLC、Rhenovia Pharmaation Plus、Schrodation Plusc.Schrodation Plusc、Schrodation Pluscity、Schrodation。
透過利用本報告中提出的見解，各公司的行銷負責人和經營團隊將能夠就未來的產品發布、產品升級、市場擴張和行銷策略做出明智的決策。
這份全球計算生物學市場報告的目標受群眾外包括產業內的各種相關人員，例如投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
透過各種用於分析全球計算生物學市場的策略矩陣，相關人員將能夠更輕鬆地做出決策。

北美洲
- 美國
- 加拿大
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲國家
歐洲
- 英國
- 德國
- 義大利
- 法國
- 西班牙
- 俄羅斯
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- ASEAN
- 澳洲
- 韓國
- 其他亞太國家
中東
- GCC
- 以色列
- 其他中東國家
非洲
- 北非
- 中非
- 南非

第7章競爭情勢

Accelrys
Certara, LP
Chemical Computing Group Inc.
Compugen, ltd.
Entelos, Inc.（Rosa and Co. LLC）
Genedata AG
Insilico Biotechnology AG
Leadscope, Inc.
Nimbus Discovery LLC
Rhenovia Pharma SAS
Schrodinger
Simulation Plus, Inc.

第8章

調查方法
關於本公司

簡介目錄

Product Code: CMI3915

Computational Biology Market is estimated to be valued at USD 10.76 Bn in 2026 and is expected to reach USD 33.86 Bn by 2033, growing at a compound annual growth rate (CAGR) of 17.8% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 10.76 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	17.80%	2033 Value Projection:	USD 33.86 Bn

Computational biology aims to advance healthcare by developing computational models of diseases, personalizing these models using data from patients, and applying these models to improve the diagnosis and treatment of diseases. These patient models are used to discover novel risk biomarkers, predict disease progression, design optimal treatments, and identify new drug targets for applications such as cancer, cardiovascular disease, and neurological disorders. The development and application of patient-specific, quantitative models can be used to understand, diagnose, and treat disease. Computational medicines can be used for molecular, physiological, and anatomical medicines. The integration of biomedical signal processing, computational modeling, machine learning, and health informatics can be done to develop new approaches in personalized medicine via electronic health records, physiological time series data, and genomics.

Market Dynamics

The increasing launch of new products, mergers, and acquisitions by key market players is expected to drive the global computational biology market growth. For instance, on July 25, 2022, Replay, a U.S.-based genome writing company, received USD 55 Mn in seed financing. The round was led by KKR and OMX Ventures, with additional participation from ARTIS Ventures and Lansdowne Partners, SALT, DeciBio Ventures, and Axial. Replay's genomic medicine toolkit encompasses a portfolio of disruptive platform technologies to write and deliver big DNA, including a high payload capacity HSV delivery platform, a hypoimmunogenic cell therapy platform, and a proprietary genome writing platform. The Replay, a U.S.-based genome writing company solves challenges in currently limiting clinical progress including increased payload capacity, off the shelf cell therapies that can reduce the cost of goods, improve production speed, volume and consistency, and expand the potential for genome engineering.

Key features of the study

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global computational biology market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
The key companies covered as a part of this study include Accelrys, Certara, L.P., Chemical Computing Group Inc., Compugen, Ltd., Entelos, Inc. (Rosa & Co. LLC), Genedata AG, Insilico Biotechnology AG, Leadscope, Inc., Nimbus Discovery LLC, Rhenovia Pharma SAS, Schrodinger, and Simulation Plus, Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
The global computational biology market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global computational biology market.

Market Segmentation

Global Computational Biology Market, By Type (Revenue, USD Bn, 2021 - 2033)
Cellular and Biological Simulation
- Computational Genomics
- Computational Proteomics
- Pharmacogenomics
- Others (Transcriptomics/Metabolomic)
Disease Modeling and Simulation Applications
- Drug Discovery
- Drug Development
Global Computational Biology Market, By Tools (Revenue, USD Bn, 2021 - 2033)
Content/Database
Analysis Software and Services
IT Infrastructure (Hardware)
Global Computational Biology Market, By Region (Revenue, USD Bn, 2021 - 2033)
North America
- U.S.
- Canada
Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
Europe
- U.K.
- Germany
- France
- Spain
- Italy
- Russia
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
Middle East
- GCC Countries
- Israel
- Rest of Middle East
Africa
- North Africa
- Central Africa
- South Africa
Company Profiles
Accelrys
Certara, L.P.
Chemical Computing Group Inc.
Compugen, ltd.
Entelos, Inc. (Rosa & Co. LLC)
Genedata AG
Insilico Biotechnology AG
Leadscope, Inc.
Nimbus Discovery LLC
Rhenovia Pharma SAS
Schrodinger
Simulation Plus, Inc.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Type
- Market Snapshot, By Tools
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Recent Product Launches
Epidemiology
Merger, Acquisition, and Collaborations
Regulatory Scenario
Key Developments
PEST Analysis

4. Global Computational Biology Market, By Type, 2021 - 2033, (USD Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Cellular and Biological Simulation
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  - Computational Genomics
  - Computational Proteomics
  - Pharmacogenomics
  - Others (Transcriptomics/Metabolomic)
Disease Modeling and Simulation Applications
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
  - Drug Discovery
  - Drug Development

5. Global Computational Biology Market, By Tools, 2021 - 2033, (USD Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Content/Database
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Analysis Software and Services
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
IT Infrastructure (Hardware)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

6. Global Computational Biology Market, By Region, 2021 - 2033, (USD Bn)

Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Region, 2021 - 2033
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Tools, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Tools, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Tools, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Tools, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Tools, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Tools, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Sub-region, 2021 - 2033, (USD Bn)
  - North Africa
  - Central Africa
  - South Africa

7. Competitive Landscape

Accelrys
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Certara, L.P.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Chemical Computing Group Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Compugen, ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Entelos, Inc. (Rosa and Co. LLC)
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Genedata AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Insilico Biotechnology AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Leadscope, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Nimbus Discovery LLC
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Rhenovia Pharma SAS
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Schrodinger
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Simulation Plus, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies